| American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early … D Saslow, D Solomon, HW Lawson, M Killackey, SL Kulasingam, J Cain, ... American journal of clinical pathology 137 (4), 516-542, 2012 | 3165 | 2012 |
| Sustained efficacy up to 4· 5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial DM Harper, EL Franco, CM Wheeler, AB Moscicki, B Romanowski, ... The Lancet 367 (9518), 1247-1255, 2006 | 2264 | 2006 |
| American Cancer Society guideline for the early detection of cervical neoplasia and cancer D Saslow, CD Runowicz, D Solomon, AB Moscicki, RA Smith, HJ Eyre, ... CA: a cancer journal for clinicians 52 (6), 342-362, 2002 | 1494 | 2002 |
| 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors RB Perkins, RS Guido, PE Castle, D Chelmow, MH Einstein, F Garcia, ... Journal of lower genital tract disease 24 (2), 102-131, 2020 | 878 | 2020 |
| Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females AB Moscicki, N Hills, S Shiboski, K Powell, N Jay, E Hanson, S Miller, ... Jama 285 (23), 2995-3002, 2001 | 858 | 2001 |
| The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women AB Moscicki, S Shiboski, J Broering, K Powell, L Clayton, N Jay, ... The Journal of pediatrics 132 (2), 277-284, 1998 | 800 | 1998 |
| Comprehensive control of human papillomavirus infections and related diseases FX Bosch, TR Broker, D Forman, AB Moscicki, ML Gillison, J Doorbar, ... Vaccine 31, H1-H31, 2013 | 784 | 2013 |
| Updating the natural history of HPV and anogenital cancer AB Moscicki, M Schiffman, S Kjaer, LL Villa Vaccine 24, S42-S51, 2006 | 781 | 2006 |
| American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors D Saslow, PE Castle, JT Cox, DD Davey, MH Einstein, DG Ferris, ... CA: a cancer journal for clinicians 57 (1), 7-28, 2007 | 743 | 2007 |
| Regression of low-grade squamous intra-epithelial lesions in young women AB Moscicki, S Shiboski, NK Hills, KJ Powell, N Jay, EN Hanson, S Miller, ... The Lancet 364 (9446), 1678-1683, 2004 | 633 | 2004 |
| Effectiveness of a quality improvement intervention for adolescent depression in primary care clinics: a randomized controlled trial JR Asarnow, LH Jaycox, N Duan, AP LaBorde, MM Rea, P Murray, ... Jama 293 (3), 311-319, 2005 | 596 | 2005 |
| Updating the natural history of human papillomavirus and anogenital cancers AB Moscicki, M Schiffman, A Burchell, G Albero, AR Giuliano, ... Vaccine 30, F24-F33, 2012 | 546 | 2012 |
| External genital warts: diagnosis, treatment, and prevention DJ Wiley, J Douglas, K Beutner, T Cox, K Fife, AB Moscicki, L Fukumoto Clinical Infectious Diseases 35 (Supplement_2), S210-S224, 2002 | 525 | 2002 |
| Early drinking onset and its association with alcohol use and problem behavior in late adolescence E Gruber, RJ DiClemente, MM Anderson, M Lodico Preventive medicine 25 (3), 293-300, 1996 | 473 | 1996 |
| Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years. B Romanowski, PC de Borba, PS Naud, CM Roteli-Martins, ... Lancet (London, England) 374 (9706), 1975-1985, 2009 | 381 | 2009 |
| Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women AB Moscicki, Y Ma, C Wibbelsman, TM Darragh, A Powers, S Farhat, ... Obstetrics & Gynecology 116 (6), 1373-1380, 2010 | 376 | 2010 |
| Cell-mediated immune response to human papillomavirus infection M Scott, M Nakagawa, AB Moscicki Clinical Diagnostic Laboratory Immunology 8 (2), 209-220, 2001 | 366 | 2001 |
| Impact of HPV infection in adolescent populations AB Moscicki Journal of Adolescent Health 37 (6), S3-S9, 2005 | 346 | 2005 |
| Human papillomavirus, human immunodeficiency virus and immunosuppression LA Denny, S Franceschi, S de Sanjosé, I Heard, AB Moscicki, J Palefsky Vaccine 30, F168-F174, 2012 | 338 | 2012 |
| Barriers to HAART adherence among human immunodeficiency virus–infected adolescents DA Murphy, M Sarr, SJ Durako, AB Moscicki, CM Wilson, LR Muenz, ... Archives of pediatrics & adolescent medicine 157 (3), 249-255, 2003 | 293 | 2003 |
Anna Barbara MoscickiProfessor of Pediatrics, University of California, Los AngelesVerified email at mednet.ucla.edu
